(BUSINESS WIRE)--Verastem, Inc., a biopharmaceutical company focused on discovering and developing drugs to treat cancer by targeting cancer stem cells, announced today that it will be presenting at the 29th Annual J.P. Morgan Healthcare Conference at 12:30 pm PST (3:30 pm EST) on Thursday, January 13th, 2011. The presentation will focus on the Company’s strategy for translating breakthrough discoveries in cancer stem cell research into new medicines for the treatment of major cancers.
